Publications by authors named "D Hernandez Herrero"

Introduction: Adequate control of patient blood volume in hemodialysis (HD) is essential as a modifiable risk factor for morbidity and mortality. In this study, we propose continuous non-invasive hemodynamic monitoring using bioreactance (Starling SV.Baxter) and real-time characterization of cardiac preload data to aid in the accurate assessment of volume status and improvement of tolerance in HD.

View Article and Find Full Text PDF

The adult mammalian heart has been demonstrated to be endowed with low but real turnover capacity, especially for cardiomyocytes, the key functional cell type. The source, however, of that turnover capacity remains controversial. In this regard, we have defined and characterized a resident multipotent cardiac mouse progenitor population, +DR (for + Damage-Responsive cells).

View Article and Find Full Text PDF

Hepatitis delta virus (HDV) infection represents the most severe form of human viral hepatitis; however, the mechanisms underlying its pathology remain incompletely understood. We recently developed an HDV mouse model by injecting adeno-associated viral vectors (AAV) containing replication-competent HBV and HDV genomes. This model replicates many features of human infection, including liver injury.

View Article and Find Full Text PDF

Oxidative stress-induced myocardial apoptosis and necrosis are critically involved in ischemic infarction, and several sources of extracellular vesicles appear to be enriched in therapeutic activities. The central objective was to identify and validate the differential exosome miRNA repertoire in human cardiac progenitor cells (CPC). CPC exosomes were first analyzed by LC-MS/MS and compared by RNAseq with exomes of human mesenchymal stromal cells and human fibroblasts to define their differential exosome miRNA repertoire (exo-miR).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the use of nebulized voriconazole for treating fungal lung diseases, noting its potential benefits like better lung penetration and fewer side effects compared to other delivery methods.
  • It involved ten patients (nine adults and one child) who received compounded voriconazole solutions, showing no adverse effects and no drug absorption into the bloodstream.
  • The findings suggest nebulized voriconazole could be a viable option, but more research is necessary to evaluate its effectiveness in treating these conditions.
View Article and Find Full Text PDF